• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT IIS BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ESBF2814C103EE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Fever (1858)
Event Date 03/28/2024
Event Type  Injury  
Manufacturer Narrative
Continuation of d10: section d information references the main component of the system.Other relevant device(s) are: product id: e tlw1620c156ee, serial/lot #: (b)(6), ubd: 08-feb-2026, udi#: (b)(4) ; product id: etlw1616c156ee, serial/lot #: (b)(6), ubd: 20-dec-2025, udi#: (b)(4).Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event Description
An endurant ii/iis stent graft was implanted as part of the advance study for the treatment of an abdominal aortic aneurysm.It was reported that the day after the procedure, the patient experienced fever symptoms of 39.5 °c.The reported fever required prolonged hospitalization and blood cultures were taken.The patient recovered on (b)(6) 2023 and was discharged with a normal temperature of 37.3 °c.The results of the blood culture showed no growth of bacteria.The site assessed the fever as having a possibly related to the index procedure, while the site assessed as probably related to the index procedure.The site and sponsor assessed the fever as possibly related to the study device and not related to an underlying condition or disease.Both stated that implant of evar could cause post operative fever.No additional clinical sequalae were provided and the patient is fine.
 
Manufacturer Narrative
B5; additional information received; the site and sponsor have now assessed the fever as not related to the study device.The sponsor assessed the fever as causally related to the index procedure.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT IIS BIFURCATED STENT GRAFT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key19095062
MDR Text Key339985554
Report Number9612164-2024-01765
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeNL
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/20/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESBF2814C103EE
Device Catalogue NumberESBF2814C103EE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/29/2024
Initial Date FDA Received04/12/2024
Supplement Dates Manufacturer Received05/17/2024
Supplement Dates FDA Received05/20/2024
Date Device Manufactured12/13/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
"SEE H11...."
Patient Outcome(s) Hospitalization;
Patient Age71 YR
Patient SexMale
Patient Weight115 KG
-
-